WuXi Advanced Therapies Supports First Investigational CD19 CAR-T Therapy Approved by China’s NMPA
Latest Articles
All articles
Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201
WuXi ATU and T-MAXIMUM Announce Strategic Partnership of Cooperation for MT-027 UCAR-T
Clinical Phase I/II IND Approval! The first cell therapy project in Korea supported by WuXi Advanced Therapies receives MFDS approval
WuXi Advanced Therapies Announces Licensing Agreement with Janssen
WuXi Advanced Therapies Testing Facility To Receive EMA GMP Certificate for New Philadelphia Facility
Subscribe to our newsletter
Receive Our latest insights and news
Upcoming Events
Resources
Gain access to white papers, posters, videos, case studies, brochures and more.
